Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 5Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unresectable Hepatocellular Carcinoma 1Stomatitis 1Respiratory Aspiration 1Recurrence 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Periodontitis 1Pain 1Ovariancancer 1Ovarian Neoplasms 1Non Small Cell Lung Caner 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Myasthenia Gravis 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Calculi 1Inflammatory Breast Neoplasms 1Immune Checkpoint Inhibitor-Induced Dermatitis 1Head and Neck Neoplasms 1Febrile Neutropenia 1Fatigue 1Dupuytren Contracture 1Depression 1

Interventions

Cyclophosphamide 6fludarabine 5toripalimab 3Paclitaxel 3Etoposide 3Carboplatin 3Bevacizumab 3zimberelimab 2tislelizumab 2sintilimab 2glumetinib 2Vincristine 2Temozolomide 2Platinum 2Immune Checkpoint Inhibitors 2Hepatectomy 2Gemcitabine 2Drug Therapy 2Docetaxel 2Cisplatin 2Capecitabine 2venetoclax 1relmacabtagene autoleucel 1osimertinib 1lenvatinib 1irinotecan sucrosofate 1glofitamab 1gallium maltolate 1fludarabine phosphate 1eribulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Recurrence × Therapeutics × Clear all
NCT07542717 2026-04-21

ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Not yet recruiting
41 enrolled
Gynecologic

Uterine Cervical Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡